UNIVERSITY OF UTAH
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1850-02-28
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.utah.edu
Moderate Sedation Educational Software
Terminated
- Conditions
- Interventions
- First Posted Date
- 2008-07-02
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 38
- Registration Number
- NCT00708760
- Locations
- 🇺🇸
University of Utah, Salt Lake City, Utah, United States
Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
- First Posted Date
- 2008-07-02
- Last Posted Date
- 2017-06-01
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 11
- Registration Number
- NCT00708721
- Locations
- 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States
Improved Patient Recovery After Anesthesia With Hypercapnia Hyperpnoea
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-07-02
- Last Posted Date
- 2022-11-29
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 22
- Registration Number
- NCT00708526
- Locations
- 🇺🇸
University of Utah, Salt Lake City, Utah, United States
Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-06-30
- Last Posted Date
- 2013-07-31
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 90
- Registration Number
- NCT00707174
- Locations
- 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States
Combination of Hydroxyurea and Verapamil for Refractory Meningiomas
- First Posted Date
- 2008-06-30
- Last Posted Date
- 2017-04-13
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 8
- Registration Number
- NCT00706810
- Locations
- 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States
[F-18] Fluorothymidine (FLT) Imaging on Patients With Primary Brain Tumors
- First Posted Date
- 2008-06-30
- Last Posted Date
- 2021-10-15
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 15
- Registration Number
- NCT00707343
- Locations
- 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States
FDG-Positron Emission Tomography (PET)/CT In the Evaluation of Persistent Febrile Neutropenia in Cancer Patients
- First Posted Date
- 2008-06-30
- Last Posted Date
- 2022-04-27
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 19
- Registration Number
- NCT00707213
- Locations
- 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States
Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2008-06-30
- Last Posted Date
- 2017-03-31
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 6
- Registration Number
- NCT00707161
- Locations
- 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States
🇺🇸LDS Hospital, Salt Lake City, Utah, United States
Radiation Therapy and Capecitabine/Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas Adenocarcinoma
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-06-30
- Last Posted Date
- 2014-10-31
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 13
- Registration Number
- NCT00707278
- Locations
- 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States
Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor Response
- First Posted Date
- 2008-06-10
- Last Posted Date
- 2015-12-01
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 25
- Registration Number
- NCT00694096
- Locations
- 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States
© Copyright 2024. All Rights Reserved by MedPath